
|Articles|March 1, 2008
Alcon's Cary Rayment honored as a 'catalyst' for glaucoma work
Cary Rayment, who was honored Jan. 23 by the Glaucoma Research Foundation (GRF) with the 2008 GRF Catalyst Award, is leading his company's strategic plan to spend more than $3.5 billion on research over the next 5 years.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
The Residency Report: Cardiovascular risk scores as a window into ocular disease
3
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
4
FDA guidance to help accelerate cell and gene therapies
5





















